131 related articles for article (PubMed ID: 24684252)
1. Age disparities in survival from lymphoma and myeloma: a comparison between US and England.
Pulte D; Redaniel MT; Lowry L; Bird J; Jeffreys M
Br J Haematol; 2014 Jun; 165(6):824-31. PubMed ID: 24684252
[TBL] [Abstract][Full Text] [Related]
2. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
[TBL] [Abstract][Full Text] [Related]
3. Advance and stagnation in the treatment of patients with lymphoma and myeloma: Analysis using population-based cancer registry data in Japan from 1993 to 2006.
Chihara D; Ito H; Izutsu K; Hattori M; Nishino Y; Ioka A; Matsuda T; Ito Y
Int J Cancer; 2015 Sep; 137(5):1217-23. PubMed ID: 25694231
[TBL] [Abstract][Full Text] [Related]
4. Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century.
Pulte D; Redaniel MT; Bird J; Jeffreys M
Eur J Haematol; 2015 Jun; 94(6):540-5. PubMed ID: 25315799
[TBL] [Abstract][Full Text] [Related]
5. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
6. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century.
Pulte D; Jansen L; Gondos A; Emrich K; Holleczek B; Katalinic A; Brenner H;
Br J Haematol; 2014 Mar; 164(6):851-7. PubMed ID: 24433418
[TBL] [Abstract][Full Text] [Related]
7. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
[TBL] [Abstract][Full Text] [Related]
8. Expected long-term survival of older patients diagnosed with non-Hodgkin lymphoma in 2008-2012.
Pulte D; Gondos A; Brenner H
Cancer Epidemiol; 2012 Feb; 36(1):e19-25. PubMed ID: 21959230
[TBL] [Abstract][Full Text] [Related]
9. Survival of Danish cancer patients 1943-1987. Lymphatic and haematopoietic tissues.
Strom HH; Clemmensen IH
APMIS Suppl; 1993; 33():183-213. PubMed ID: 8512739
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
11. Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.
Karalexi MA; Georgakis MK; Dessypris N; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Bouka E; Dana H; Hatzipantelis E; Kourti M; Moschovi M; Polychronopoulou S; Stiakaki E; Pourtsidis A; Petridou ET
Hematol Oncol; 2017 Dec; 35(4):608-618. PubMed ID: 27641612
[TBL] [Abstract][Full Text] [Related]
12. Survival disparities by age and country of diagnosis for patients with acute leukemia.
Redaniel MT; Pulte D; Jeffreys M
Leuk Lymphoma; 2015; 56(10):2787-92. PubMed ID: 25669926
[TBL] [Abstract][Full Text] [Related]
13. Survival trends in elderly myeloma patients.
Jones A; Bowcock S; Rachet B
Eur J Haematol; 2021 Jan; 106(1):126-131. PubMed ID: 33037667
[TBL] [Abstract][Full Text] [Related]
14. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
Pulte D; Gondos A; Brenner H
Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age.
Yaqo RT; Jalal SD; Ghafour KJ; Hassan HA; Hughson MD
J Glob Oncol; 2019 Apr; 5():1-10. PubMed ID: 30978153
[TBL] [Abstract][Full Text] [Related]
16. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century.
Pulte D; Jansen L; Castro FA; Emrich K; Katalinic A; Holleczek B; Brenner H;
Br J Haematol; 2015 Oct; 171(2):189-196. PubMed ID: 26123295
[TBL] [Abstract][Full Text] [Related]
17. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
18. Variation in incidence and survival by ethnicity for patients with myeloma in England (2002-2008).
Samy EF; Ross J; Bolton E; Morris EJ; Oliver SE
Leuk Lymphoma; 2015; 56(9):2660-7. PubMed ID: 25651425
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma in adolescents and young adults.
Jaglowski SM; Linden E; Termuhlen AM; Flynn JM
Semin Oncol; 2009 Oct; 36(5):381-418. PubMed ID: 19835736
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
Soutar RL; Dawson AA; Wilson BJ
Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]